15세 여아에서 발생한 폐포단백증 1예
Pulmonary alveolar proteinosis in a 15-year-old girl
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Pulmonary alveolar proteinosis (PAP) is a diffuse lung disease characterized by the accumulation of lipoproteins derived from surfactants in the distal air space. The lack of granulocyte macrophage colony-stimulating factor is believed to contribute to macrophage dysfunction and the impaired processing of surfactants. Because the prevalence of PAP in the general population is less than 1 in 200,000, and the typical age at presentation is 35 to 50 years, PAP is a very rare disease in children. To the best of our knowledge, there has been no Korean report on PAP in children. We describe here a patient who was diagnosed with PAP at the aged 15 years.
Abstract
Pulmonary alveolar proteinosis (PAP) is a diffuse lung disease characterized by the accumulation of lipoproteins derived from surfactants in the distal air space. The lack of granulocyte macrophage colony-stimulating factor is believed to contribute to macrophage dysfunction and the impaired processing of surfactants. Because the prevalence of PAP in the general population is less than 1 in 200,000, and the typical age at presentation is 35 to 50 years, PAP is a very rare disease in children. To the best of our knowledge, there has been no Korean report on PAP in children. We describe here a patient who was diagnosed with PAP at the aged 15 years.
참고문헌 (15)
- Trapnell BC, "Pulmonary alveolar proteinosis", N Engl J Med, 349, pp.2527~2539 (2003)
- Carey B, "The molecular basis of pulmonary alveolar proteinosis", Clin Immunol, 135, pp.223~235 (2010)
- Froudarakis ME, "Total lung lavage by awake flexible fiberoptic bronchoscope in a 13-year-old girl with pulmonary alveolar proteinosis", Respir Med, 101, pp.366~369 (2007)
- 변민광, "Clinical Features and Outcomes of Idiopathic Pulmonary Alveolar Proteinosis in Korean Population", Journal of Korean Medical Science, 25(3), pp.393~398 (2010), 대한의학회
- Suzuki T, "Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA", J Exp Med, 205, pp.2703~2710 (2008)
- Woo DH, "A case of pulmonary alveolar proteinosis", Yeungnam Univ J Med, 27, pp.57~62 (2010)
- Rosen SH, "Pulmonary alveolar proteinosis", N Engl J Med, 258, pp.1123~1142 (1958)
- Stanley E, "Granulocyte", macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology, 1994, pp.91, 5592~5596
- Kitamura T, "Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte", macrophage colony-stimulating factor, 1999, pp.190, 875~880
- Suzuki T, "Hereditary pulmonary alveolar proteinosis: pathogenesis, presentation, diagnosis, and therapy", Am J Respir Crit Care Med, 182, pp.1292~1304 (2010)
- Ceruti M, "Successful whole lung lavage in pulmonary alveolar proteinosis secondary to lysinuric protein intolerance : a case report", Orphanet J Rare Dis, 2, pp.14~ (2007)
- Wang BM, "Diagnosing pulmonary alveolar proteinosis. A review and an update", Chest, 111, pp.460~466 (1997)
- Seymour JF, "Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis", Am J Respir Crit Care Med, 163, pp.524~531 (2001)
- 송준휘, "전폐 세척술로 부분 관해 후 GM-CSF 투여로 치료된 특발성 폐포단백증 1예", Tuberculosis and Respiratory Diseases, 67(6), pp.569~573 (2009), 대한결핵및호흡기학회
- Tazawa R, "Inhaled granulocyte", macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis, 2010, pp.181, 1345~1354